Supriya Lifescience Ltd Inaugurates State-of-the-Art Module E Production Block at Lote Parshuram, Maharashtra

New Delhi: Supriya Lifescience Ltd (SLL), a leader in the pharmaceutical industry, has taken another significant step on its ambitious growth trajectory with the inauguration of its new multipurpose Active Pharmaceutical Ingredients (APIs) production block, Module E, at the Lote Parshuram site. The facility, developed with an investment of approximately ₹120 crore, adds a substantial capacity of 335 kiloliters to the company’s operations. This expansion boosts our Lote Parshuram capacity by over 55%, increasing it from 597 KLPD to 932 KLPD.

The new production block is designed to support SLL’s strategic focus on expanding its R&D capabilities and scaling up its pipeline of innovative products. Several new products in niche therapeutic areas are nearing the commercialization stage, reinforcing SLL’s commitment to achieving a leadership position in these markets through efficient processes and backward integration.